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required to establish the overall effectiveness of their method
both in the animal model and in human beings.
Roberto Scrofani, MD
Divisione di Chirurgia Cardiovascolare
Ospedale “L. Sacco”
Via G. B. Grassi n.74
20157 Milan, Italy
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Reply to the Editor:
Dr Scrofani and his colleagues in Milan are to be congrat-
ulated for carrying out these fluoroscopic studies of implant-
ed radiopaque mitral annular markers in human subjects.
Scrofani’s letter alludes to the radiographic results in 20
patients who had a few, relatively large (3 mm) metallic
markers inserted into a posterior mitral annuloplasty tube of
autologous pericardium, which were published in 19911 and
1996.2 The Institutional Review Board at Ospedale “L.
Sacco” and these courageous investigators deserve credit for
conducting the only human investigation that I am aware of
which employed intracardiac radiopaque markers; it is
notable that no adverse complications of the research study
were noted. When we began our myocardial marker studies in
human patients in the 1970s, we used only external or left
ventricular mid-wall myocardial markers. Our more recent
investigations of the mitral ventricular-valvular complex,
which now include upward of 10 miniature gold markers
inserted in the mitral leaflets per se in addition to the 8 annu-
lar markers, have all been performed in animal models,
including the article concerning the mitral annular ring in
sheep, which prompted Scrofani’s letter.3
Both similarities and differences between the normal sheep
and the human postmitral repair studies are noteworthy,
including the timing and amplitude of annular motion. This
Italian group attempted to reproduce in human beings the
seminal pioneering work performed by Tsakiris and col-
leagues4-6 in dogs at the Mayo Clinic in the 1960s.
Importantly, only single-plane fluoroscopy was used, as was
the case in Tsakiris’s experiments, which means that cardiac
motion into and out of the plane of reference and other inter-
nal motion (translation and rotation) were not detectable. This
implies that the observed motion could possibly have not been
true internal cardiac deformation, but corrupted by artifact
resulting from cardiac translation or rotation. The high speed,
simultaneous biplane cinefluoroscopic techniques that we use
eliminate such ambiguity, because the true 3-dimensional
coordinates of each marker are identified every 17 ms with
respect to a fixed, external laboratory reference system, with
an accuracy and reproducibility of less than 1 mm.
Scrofani and associates noted that fractional area change of
the posterior mitral “hemiarea” during the cardiac cycle was
small (8.5% ± 6%) after a partial posterior pericardial annu-
loplasty; importantly, this is not dissimilar to the total mitral
annular area change of 11% ± 2% reported in our study in
control sheep.3 On the other hand, we found no mitral area
change after implantation of either a complete Duran ring
(Medtronic, Inc, Minneapolis, Minn) or a Carpentier-
Edwards Physio complete annuloplasty ring (Baxter Health-
care Corp, Irvine, Calif).3 Given the marked differences in
annuloplasty methods employed, analytical techniques used,
the experimental conditions, and the species, there is little
point in debating which measurement is more correct than the
other. Much more noteworthy is that the Italian investigators
observed a much smaller magnitude of dynamic motion of
the human annular orifice after mitral repair than did the
Japanese team of Okada and associates,7 who used extrapo-
lated 2-dimensional echocardiographic imaging to make their
measurements. Okada’s group reported mitral fractional area
reduction of 26% ± 4% in patients who had received a Duran
flexible annuloplasty ring,7 which was similar to that report-
ed echocardiographically in normal human beings by
Ormiston and coworkers8 in 1981. Again, these echocardio-
graphic methods cannot differentiate true internal cardiac
deformations from rotation and/or translation, cannot track
the motion of discrete cardiac foci, and are limited in terms
of temporal resolution, similar to the limitations inherent in
contrast left ventriculography, nuclear multigated acquisition
scanning, and magnetic resonance imaging (without radiofre-
quency tagging of discrete structural elements). Indeed, the
advent of 3-dimensional echocardiography may even have
complicated this issue more, as a recent abstract from the
Cleveland Clinic Foundation reported mitral area changes of
25% ± 10% in normal human beings and 28% ± 11% in those
who had received a Cosgrove-Edwards annuloplasty band
(Baxter Healthcare Corp, Irvine, Calif) during mitral repair.9
These large fractional mitral area changes were associated
with calculated end-diastolic mitral annular areas of 10.1 ±
3.9 cm2 in normal subjects and 11.5 ± 2.7 cm2 in patients who
had an annuloplasty, clearly much larger than one would
expect. Indeed, the normal mitral area is only 4 to 6 cm2 as
calculated from the Gorlin formula and, pathologically, mea-
sures only 6 to 8 cm2; therefore, these 3-dimensional echo
estimates of mitral area actually are supraphysiologic. This
leads one to question what the 3-dimensional echo techniques
are actually measuring. We all have been dazzled by beauti-
ful 3-dimensional echo images of mitral valve leaflets open-
ing and closing and wire-frame reconstructions of other car-
diac structures, but it must be remembered that quantitative
3-dimensional echo measurements of discrete cardiac dimen-
sions and dynamics have not yet been validated. Comparison
of 3-dimensional marker data obtained from simultaneous
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biplane high-speed cinefluoroscopy of implanted mitral
annular radiopaque markers with 3-dimensional echo data
would constitute the ideal validation benchmark, but such
investigations have not been carried out to date, either in ani-
mals or in man. To this end, our laboratory, with the necessary
video processing and coupled computer systems, would be
pleased to collaborate with any serious investigator who has
the capability to insert multiple miniature markers in the
mitral anulus in patients and obtain high-quality biplane cine-
fluoroscopic images postoperatively.
Until that day arrives, the quest for the Holy Grail con-
cerning human mitral valve pathophysiology will remain
unfulfilled; furthermore, in my opinion, until more quantita-
tive, validated 3-dimensional data are available, all 3-
dimensional echocardiographic estimates of mitral valve
area and fractional area reduction should be interpreted cau-
tiously, because they may represent gross overestimates and
reflect the motion of structures other than the mitral anulus
per se.
D. Craig Miller, MD
Department of Cardiovascular Surgery
Stanford University School of Medicine
Falk Cardiovascular Research Center, CV 243
300 Pasteur Dr
Stanford, CA 94305-5247
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A word of caution in extrapolating the riluzole
spinal cord injury protective effects obtained in a
rabbit model under ketamine anesthesia
To the Editor:
We read with great interest the excellent article titled
“Riluzole Prevents Ischemic Spinal Cord Injury Caused by
Aortic Crossclamping” by Lang-Lazdunski and associates (J
Thorac Cardiovasc Surg 1999;117:881-9). We do not doubt
the protective effects exhibited by riluzole, and we believe
this article is a significant contribution to central nervous sys-
tem protection, for which the authors are to be congratulated.
However, we would like to reiterate a point that was raised
recently concerning an article on memantine.1,2
The authors’ anesthetic included 50 mg/kg of ketamine.
Ketamine is an N-methyl-D-aspartate antagonist and known to
confer significant protection of the central nervous system
against ischemia.3,4 Since the mechanisms of action of keta-
mine and riluzole seem to be different, the likelihood of
effects being even potentiating and not only additive are real.
Thus the observed protective effects of riluzole were the result
of the effects of riluzole by itself in addition to those con-
tributed by ketamine, but their relative roles are unknown. For
definitive assessment of the protective effects of riluzole
alone, a group of rabbits anesthetized with nonprotective con-
centrations of volatile agents only, without ketamine or barbi-
turates, is essential before the data, concerning particularly the
ischemic time, can be extrapolated to human application since
ketamine is not usually used in adult human clinical practice.
We5 have found, in a similar model but without using keta-
mine, that neurologic functional recovery objectively evaluat-
ed 6 hours after reperfusion accurately reflects the subse-
quent outcome at 24 hours. We wonder whether the authors
made neurologic score evaluations early after reperfusion and
whether neurologic functional improvement was noticed
between 24 hours and 120 hours in those observed for more
than 24 hours.
Tadaomi-Alfonso Miyamoto, MD
Research Department 
Kokura Memorial Hospital
1-1 Kifunecho
Kokurakitaku
Kitakyushushi, 802-8555, Japan
Koho-J. Miyamoto MD, PhD
Assistant Professor
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